Edgestream Partners, L.P. - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 505 filers reported holding REPLIGEN CORP in Q4 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
Edgestream Partners, L.P. ownership history of REPLIGEN CORP
ValueSharesWeighting
Q1 2023$417,533
-75.7%
2,480
-75.6%
0.05%
-76.2%
Q4 2022$1,720,359
-3.4%
10,161
+6.8%
0.19%
+39.9%
Q3 2022$1,781,000
-55.5%
9,518
-61.4%
0.14%
-56.3%
Q2 2022$4,006,000
-2.3%
24,665
+13.2%
0.32%
-3.1%
Q1 2022$4,099,000
-39.2%
21,791
-14.4%
0.33%
-22.4%
Q4 2021$6,741,000
+2.8%
25,453
+12.2%
0.42%
+3.7%
Q3 2021$6,557,000
+154.2%
22,691
+75.6%
0.40%
+166.4%
Q2 2021$2,579,00012,9210.15%
Other shareholders
REPLIGEN CORP shareholders Q4 2021
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders